The Role of Lipocalin Type Prostaglandin D Synthase in Excessive Daytime Sleepiness in Patients with Narcolepsy Type 1
1.Sleep and Psychosomatic Medicine Center,Sanya Central Hospital /The Third People's Hospital of Hainan Province,Sanya 572000,China
2.Department of Respiratory Medicine,Peking University People's Hospital,Beijing 100044,China
3.Department of Anesthesiology,Peking University People's Hospital,Beijing 100044,China
*Corresponding author:YAN Han,Attending physician;E-mail:serenayh@126.com
WANG Peipei,YAN Han,LI Qinghua, et al. The Role of Lipocalin Type Prostaglandin D Synthase in Excessive Daytime Sleepiness in Patients with Narcolepsy Type 1[J]. Chinese General Practice, 2020, 23(35): 4454-4458. DOI: 10.12114/j.issn.1007-9572.2020.00.636.
王配配,闫涵,李清华等. 脂质运载蛋白型前列腺素D合成酶水平在1型发作性睡病患者日间过度嗜睡中的作用研究[J]. 中国全科医学, 2020, 23(35): 4454-4458. DOI: 10.12114/j.issn.1007-9572.2020.00.636.
[1]American Academy of Sleep Medicine.International classification of sleep disorders[M].3rd ed.Darien IL:American Academy of Sleep Medicine,2014:146-160.
[2]LIN L,FARACO J,LI R,et al.The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene[J].Cell,1999,98(3):365-376.DOI:10.1016/s0092-8674(00)81965-0.
[3]MIGNOT E,LAMMERS G J,RIPLEY B,et al.The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias[J].Arch Neurol,2002,59(10):1553-1562.DOI:10.1001/archneur.59.10.1553.
[4]KORNUM B R,KNUDSEN S,OLLILA H M,et al.Narcolepsy[J].Nat Rev Dis Primers,2017,3:16100.DOI:10.1038/nrdp.2016.100.
[5]SCAMMELL T E.Narcolepsy[J].N Engl J Med,2015,373(27):2654-2662.DOI:10.1056/NEJMra1500587.
[6]ZHANG J,HAN F.Sleepiness in narcolepsy[J].Sleep Med Clin,2017,12(3):323-330.DOI:10.1016/j.jsmc.2017.03.008.
[7]NISHINO S,MIGNOT E.Narcolepsy and cataplexy[J].Handb Clin Neurol,2011,99:783-814.DOI:10.1016/B978-0-444-52007-4.00007-2.
[8]KHAN Z,TROTTI L M.Central disorders of hypersomnolence:focus on the narcolepsies and idiopathic hypersomnia[J].Chest,2015,148(1):262-273.DOI:10.1378/chest.14-1304.
[9]BORBéLY A A,TOBLER I.Endogenous sleep-promoting substances and sleep regulation[J].Physiol Rev,1989,69(2):605-670.DOI:10.1152/physrev.1989.69.2.605.
[10]SAGAWA Y,SATO M,SAKAI N,et al.Wake-promoting effects of ONO-4127Na,a prostaglandin DP1 receptor antagonist,in hypocretin/orexin deficient narcoleptic mice[J].Neuropharmacology,2016,110(Pt A):268-276.DOI:10.1016/j.neuropharm.2016.07.013.
[11]SADAM H,PIHLAK A,KIVIL A,et al.Prostaglandin D2 receptor DP1 antibodies predict vaccine-induced and spontaneous narcolepsy type 1:large-scale study of antibody profiling[J].EBio Medicine,2018,29:47-59.DOI:10.1016/j.ebiom.2018.01.043.
[12]QU W M,HUANG Z L,XU X H,et al.Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep[J].Proc Natl Acad Sci USA,2006,103(47):17949-17954.DOI:10.1073/pnas.0608581103.
[13]BARCELó A,DE LA PE?A M,BARBé F,et al.Prostaglandin D synthase (beta trace) levels in sleep apnea patients with and without sleepiness[J].Sleep Med,2007,8(5):509-511.
[14]JORDAN W,TUMANI H,COHRS S,et al.Narcolepsy increased L-PGDS (beta-trace) levels correlate with excessive daytime sleepiness but not with cataplexy[J].J Neurol,2005,252(11):1372-1378.DOI:10.1007/s00415-005-0870-4.
[15]BASSETTI C L,HERSBERGER M,BAUMANN C R.CSF prostaglandin D synthase is reduced in excessive daytime sleepiness[J].J Neurol,2006,253(8):1030-1033.DOI:10.1007/s00415-006-0153-8.
[16]BERRY R B,BUDHIRAJA R,GOTTLIEB D J,et al.Rules for scoring respiratory events in sleep:update of the 2007 AASM manual for the scoring of sleep and associated events[J].J Clin Sleep Med,2012,8(5):597-619.DOI:10.5664/jcsm.2172.
[17]KUSHIDA C A,LITTNER M R,MORGENTHALER T,et al.Practice parameters for the indications for polysomnography and related procedures:an update for 2005[J].Sleep,2005,28(4):499-521.DOI:10.1093/sleep/28.4.499.
[18]董霄松,李玉茜,李静,等.脑脊液下丘脑分泌素水平测定对中国发作性睡病患者的诊断价值[J].中华医学杂志,2013,93(26):2038-2042.
[19]ODA H,SHIINA Y,SEIKI K,et al.Development and evaluation of a practical ELISA for human urinary lipocalin-type prostaglandin D synthase[J].Clin Chem,2002,48(9):1445-1453.
[20]BASSETTI C L A,ADAMANTIDIS A,BURDAKOV D,et al.Narcolepsy - clinical spectrum,aetiopathophysiology,diagnosis and treatment[J].Nat Rev Neurol,2019,15(9):519-539.DOI:10.1038/s41582-019-0226-9.
[21]URADE Y,HAYAISHI O.Prostaglandin D2 and sleep/wake regulation[J].Sleep Med Rev,2011,15(6):411-418.DOI:10.1016/j.smrv.2011.08.003.
[22]REIBER H.Proteins in cerebrospinal fluid and blood:barriers,CSF flow rate and source-related dynamics[J].Restor Neurol Neurosci,2003,21(3/4):79-96.
[23]HAYAISHI O,URADE Y,EGUCHI N,et al.Genes for prostaglandin d synthase and receptor as well as adenosine A2A receptor are involved in the homeostatic regulation of nrem sleep[J].Arch Ital Biol,2004,142(4):533-539.
[24]JORDAN W,TUMANI H,COHRS S,et al.Prostaglandin D synthase (beta-trace) in healthy human sleep[J].Sleep,2004,27(5):867-874.DOI:10.1093/sleep/27.5.867.
[25]TUMANI H,NAU R,FELGENHAUER K.Beta-trace protein in cerebrospinal fluid:a blood-CSF barrier-related evaluation in neurological diseases[J].Ann Neurol,1998,44(6):882-889.DOI:10.1002/ana.410440606.
[26]TUMANI H,REIBER H,NAU R,et al.Beta-trace protein concentration in cerebrospinal fluid is decreased in patients with bacterial meningitis[J].Neurosci Lett,1998,242(1):5-8.
[27]DE LECEA L,KILDUFF T S,PEYRON C,et al.The hypocretins:hypothalamus-specific peptides with neuroexcitatory activity[J].Proc Natl Acad Sci USA,1998,95(1):322-327.DOI:10.1073/pnas.95.1.322.
[28]SAKURAI T,AMEMIYA A,ISHII M,et al.Orexins and orexin receptors:a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior [J].Cell,1998,92(4):573-585.